130658-13-8 Usage
Uses
Used in Pharmaceutical Industry:
TERT-BUTYL 6-HYDROXY-HEXAHYDROCYCLOPENTA[C]PYRROLE-2(1H)-CARBOXYLATE is used as a building block for the synthesis of pharmaceuticals due to its unique structure and functional groups. It contributes to the development of new drugs and medicinal compounds.
Used in Organic Chemistry Research:
In the field of organic chemistry, TERT-BUTYL 6-HYDROXY-HEXAHYDROCYCLOPENTA[C]PYRROLE-2(1H)-CARBOXYLATE is used as a valuable reagent for various research purposes. Its unique properties allow chemists to explore new reactions and syntheses, expanding the scope of organic chemistry.
Used in Organic Compound Synthesis:
TERT-BUTYL 6-HYDROXY-HEXAHYDROCYCLOPENTA[C]PYRROLE-2(1H)-CARBOXYLATE is used as a building block in the synthesis of various organic compounds. Its functional groups enable the formation of new chemical entities with potential applications in different industries.
Check Digit Verification of cas no
The CAS Registry Mumber 130658-13-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,3,0,6,5 and 8 respectively; the second part has 2 digits, 1 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 130658-13:
(8*1)+(7*3)+(6*0)+(5*6)+(4*5)+(3*8)+(2*1)+(1*3)=108
108 % 10 = 8
So 130658-13-8 is a valid CAS Registry Number.
InChI:InChI=1/C12H21NO3/c1-12(2,3)16-11(15)13-6-8-4-5-10(14)9(8)7-13/h8-10,14H,4-7H2,1-3H3
130658-13-8Relevant academic research and scientific papers
ANTAGONISTS OF THE MUSCARINIC ACETYLCHOLINE RECEPTOR M4
-
Paragraph 00221, (2019/05/22)
Disclosed herein are substituted hexahydro-1H-cyclopenta[c]pyrrole compounds, which may be useful as antagonists of the muscarinic acetylcholine receptor M4 (mAChR M4). Also disclosed herein are methods of making the compounds, pharmaceutical compositions comprising the compounds, and methods of treating disorders using the compounds and compositions.
CYCLOPENTA[C]PYRROLE-2-CARBOXYLATE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF
-
Page/Page column 13, (2012/04/23)
The invention relates to compounds of the general formula (I) where: R2 is a hydrogen or fluorine atom or a hydroxyl, cyano, trifluoromethyl, C1-6-alkyl, C1-6-alkoxy, or NR8R9 group; m, n, o and p ind
N-ALKYL-AZACYCLOALKYL NMDA/NR2B ANTAGONISTS
-
, (2008/06/13)
Compounds represented by Formula (I): and/or pharmaceutically acceptable salts, individual enantiomers and stereoisomers thereof, are effective as NMDA/NR2B antagonists useful for treating conditions such as pain, Parkinson’s disease, Alzheimer’s disease, epilepsy, depression, anxiety, ischemic brain injury including stroke.
